IN2012DN01975A - - Google Patents
Download PDFInfo
- Publication number
- IN2012DN01975A IN2012DN01975A IN1975DEN2012A IN2012DN01975A IN 2012DN01975 A IN2012DN01975 A IN 2012DN01975A IN 1975DEN2012 A IN1975DEN2012 A IN 1975DEN2012A IN 2012DN01975 A IN2012DN01975 A IN 2012DN01975A
- Authority
- IN
- India
- Prior art keywords
- hydrogen
- pharmaceutically acceptable
- alkali metal
- metal ion
- acceptable cation
- Prior art date
Links
- 229910001413 alkali metal ion Inorganic materials 0.000 abstract 2
- 150000001768 cations Chemical class 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- -1 phosphonooxymethyl Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/54—Quaternary phosphonium compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/64—Cyclic peptides containing only normal peptide links
- C07K7/645—Cyclosporins; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
- C07F9/091—Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
- C07F9/6552—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a six-membered ring
- C07F9/65522—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a six-membered ring condensed with carbocyclic rings or carbocyclic ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- Anesthesiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Transplantation (AREA)
- Neurosurgery (AREA)
- Obesity (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Neurology (AREA)
- Nutrition Science (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
- Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US34186701P | 2001-12-21 | 2001-12-21 | |
| PCT/US2002/040748 WO2003059255A2 (fr) | 2001-12-21 | 2002-12-20 | Procede de preparation de derives de phosphonooxymethyle d'alcool et de phenol |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2012DN01975A true IN2012DN01975A (fr) | 2015-08-21 |
Family
ID=23339347
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN1975DEN2012 IN2012DN01975A (fr) | 2001-12-21 | 2002-12-20 |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US7229978B2 (fr) |
| EP (2) | EP2058320B1 (fr) |
| JP (2) | JP4369237B2 (fr) |
| KR (3) | KR20100101011A (fr) |
| CN (2) | CN100413508C (fr) |
| AT (1) | ATE423563T1 (fr) |
| AU (2) | AU2002360682B2 (fr) |
| CA (1) | CA2470423C (fr) |
| DE (1) | DE60231336D1 (fr) |
| ES (1) | ES2322245T3 (fr) |
| HU (1) | HU230216B1 (fr) |
| IL (1) | IL162550A (fr) |
| IN (1) | IN2012DN01975A (fr) |
| MX (1) | MXPA04005892A (fr) |
| NZ (1) | NZ533535A (fr) |
| PL (1) | PL205940B1 (fr) |
| RU (1) | RU2310659C2 (fr) |
| UA (1) | UA77033C2 (fr) |
| WO (1) | WO2003059255A2 (fr) |
| ZA (1) | ZA200404579B (fr) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2481285A1 (fr) | 2002-04-26 | 2003-11-06 | Gilead Sciences, Inc. | Inhibiteurs non nucleosidiques de la transcriptase inverse |
| EP1620110A2 (fr) * | 2003-04-25 | 2006-02-01 | Gilead Sciences, Inc. | Conjugues phosphonates immunomodulateurs |
| MXPA05011297A (es) | 2003-04-25 | 2006-05-25 | Gilead Sciences Inc | Analogos antivirales de fosfonato. |
| US7407965B2 (en) | 2003-04-25 | 2008-08-05 | Gilead Sciences, Inc. | Phosphonate analogs for treating metabolic diseases |
| US7300924B2 (en) | 2003-04-25 | 2007-11-27 | Gilead Sciences, Inc. | Anti-infective phosphonate analogs |
| WO2005002626A2 (fr) | 2003-04-25 | 2005-01-13 | Gilead Sciences, Inc. | Composes de phosphonate therapeutiques |
| US7432261B2 (en) | 2003-04-25 | 2008-10-07 | Gilead Sciences, Inc. | Anti-inflammatory phosphonate compounds |
| US7417055B2 (en) | 2003-04-25 | 2008-08-26 | Gilead Sciences, Inc. | Kinase inhibitory phosphonate analogs |
| US7427636B2 (en) | 2003-04-25 | 2008-09-23 | Gilead Sciences, Inc. | Inosine monophosphate dehydrogenase inhibitory phosphonate compounds |
| US7452901B2 (en) | 2003-04-25 | 2008-11-18 | Gilead Sciences, Inc. | Anti-cancer phosphonate analogs |
| US7470724B2 (en) | 2003-04-25 | 2008-12-30 | Gilead Sciences, Inc. | Phosphonate compounds having immuno-modulatory activity |
| US20040225022A1 (en) * | 2003-05-09 | 2004-11-11 | Desai Neil P. | Propofol formulation containing reduced oil and surfactants |
| US7427624B2 (en) | 2003-10-24 | 2008-09-23 | Gilead Sciences, Inc. | Purine nucleoside phosphorylase inhibitory phosphonate compounds |
| US7432273B2 (en) | 2003-10-24 | 2008-10-07 | Gilead Sciences, Inc. | Phosphonate analogs of antimetabolites |
| WO2005042773A1 (fr) | 2003-10-24 | 2005-05-12 | Gilead Sciences, Inc. | Procedes et compositions permettant d'identifier des composes therapeutiques |
| US20080287471A1 (en) | 2003-12-22 | 2008-11-20 | Maria Fardis | 4'-Substituted Carbovir And Abacavir-Derivatives As Well As Related Compounds With Hiv And Hcv Antiviral Activity |
| UA88313C2 (ru) | 2004-07-27 | 2009-10-12 | Гилиад Сайенсиз, Инк. | Фосфонатные аналоги соединений ингибиторов вич |
| CN102089318B (zh) | 2008-07-08 | 2014-05-21 | 吉里德科学公司 | Hiv抑制剂化合物的盐 |
| KR20100032803A (ko) * | 2008-09-18 | 2010-03-26 | 씨제이제일제당 (주) | 아데포비어디피복실의 개선된 제조방법 |
| CN101845057B (zh) * | 2009-03-27 | 2013-10-23 | 四川大学 | 取代苯酚的甲缩醛磷酸盐麻醉镇静药用化合物及制备方法 |
| CN102596977B (zh) * | 2009-05-07 | 2016-06-29 | 明尼苏达大学评议会 | 雷公藤内酯前药 |
| US9150600B2 (en) | 2009-05-07 | 2015-10-06 | Regents Of The University Of Minnesota | Triptolide prodrugs |
| JP2012140330A (ja) * | 2010-12-28 | 2012-07-26 | Tosoh Corp | 水溶性リン酸エステルの精製方法 |
| ITMI20110580A1 (it) * | 2011-04-08 | 2012-10-09 | Chemelectiva S R L | Iintermedi utili per la preparazione di fospropofol e processo per la loro preparazione |
| UY34072A (es) | 2011-05-17 | 2013-01-03 | Novartis Ag | Derivados sustituidos de indol |
| CN102351895A (zh) * | 2011-08-08 | 2012-02-15 | 陕西合成药业有限公司 | 甲磷丙泊酚二钠水合物及其制备方法和用途 |
| CN102516099B (zh) * | 2011-12-02 | 2013-07-17 | 成都苑东药业有限公司 | 一种水溶性三醇胺的衍生物 |
| CN102382133B (zh) * | 2011-12-02 | 2016-03-23 | 陕西合成药业股份有限公司 | 一种磷丙泊酚钠的制备及纯化方法 |
| CN102399236A (zh) * | 2011-12-27 | 2012-04-04 | 上海立科药物化学有限公司 | 磷丙泊酚钠的合成方法 |
| CN102603798A (zh) * | 2012-02-14 | 2012-07-25 | 陕西合成药业有限公司 | 一种唑系化合物水溶性前药的制备方法 |
| PT2995604T (pt) * | 2013-05-09 | 2019-10-11 | Sichuan Haisco Pharmaceutical Co Ltd | Derivado de fenol e seu processo de preparação e utilização em medicina |
| US11331271B2 (en) | 2016-05-27 | 2022-05-17 | The Johns Hopkins University | Buccal, sublingual and intranasal delivery of fospropofol |
| SI3661937T1 (sl) | 2017-08-01 | 2021-11-30 | Gilead Sciences, Inc. | Kristalinične oblike etil((S)-((((2R,5R)-5-(6-amino-9H-purin-9-IL)-4- fluoro-2,5-dihidrofuran-2-IL)oksi)metil)(fenoksi)fosforil)-L-alaninata (GS-9131) za zdravljenje virusnih okužb |
| CN109456360B (zh) * | 2018-12-17 | 2021-05-14 | 河南中医药大学 | 一种磷丙泊酚钠的制备方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2833827A (en) * | 1955-01-17 | 1958-05-06 | Bayer Ag | Tri (3, 5-di lower alkyl-4-hydroxy phenyl)-sulfonium chlorides and method of preparing same |
| GB814278A (en) | 1956-11-13 | 1959-06-03 | Bataafsche Petroleum | Process for the preparation of 2.4.6 trialkylated phenols |
| JPS56131594A (en) * | 1980-03-17 | 1981-10-15 | Mitsui Toatsu Chem Inc | Preparation of alkyl phosphate |
| JPH04282337A (ja) * | 1991-03-08 | 1992-10-07 | Fuji Photo Film Co Ltd | ２−アリールオキシ−１−クロルプロパンの製造方法 |
| US6201257B1 (en) * | 1996-10-10 | 2001-03-13 | Advanced Scientific Concepts, Inc. | Semiconductor X-ray photocathodes devices |
| US6204257B1 (en) * | 1998-08-07 | 2001-03-20 | Universtiy Of Kansas | Water soluble prodrugs of hindered alcohols |
-
2002
- 2002-12-20 KR KR1020107017896A patent/KR20100101011A/ko not_active Application Discontinuation
- 2002-12-20 EP EP09153421A patent/EP2058320B1/fr not_active Expired - Lifetime
- 2002-12-20 CA CA2470423A patent/CA2470423C/fr not_active Expired - Fee Related
- 2002-12-20 WO PCT/US2002/040748 patent/WO2003059255A2/fr active Application Filing
- 2002-12-20 KR KR1020047009287A patent/KR101016969B1/ko not_active IP Right Cessation
- 2002-12-20 ES ES02795960T patent/ES2322245T3/es not_active Expired - Lifetime
- 2002-12-20 NZ NZ533535A patent/NZ533535A/en not_active IP Right Cessation
- 2002-12-20 AT AT02795960T patent/ATE423563T1/de not_active IP Right Cessation
- 2002-12-20 EP EP02795960A patent/EP1471920B1/fr not_active Expired - Lifetime
- 2002-12-20 PL PL370489A patent/PL205940B1/pl unknown
- 2002-12-20 US US10/498,013 patent/US7229978B2/en not_active Expired - Fee Related
- 2002-12-20 RU RU2004120071/04A patent/RU2310659C2/ru not_active IP Right Cessation
- 2002-12-20 AU AU2002360682A patent/AU2002360682B2/en not_active Ceased
- 2002-12-20 HU HU0500139A patent/HU230216B1/hu not_active IP Right Cessation
- 2002-12-20 IN IN1975DEN2012 patent/IN2012DN01975A/en unknown
- 2002-12-20 JP JP2003559420A patent/JP4369237B2/ja not_active Expired - Fee Related
- 2002-12-20 DE DE60231336T patent/DE60231336D1/de not_active Expired - Lifetime
- 2002-12-20 UA UA20040604550A patent/UA77033C2/uk unknown
- 2002-12-20 CN CNB028258827A patent/CN100413508C/zh not_active Expired - Fee Related
- 2002-12-20 CN CN200810145160XA patent/CN101367834B/zh not_active Expired - Fee Related
- 2002-12-20 KR KR1020087007455A patent/KR100937162B1/ko not_active IP Right Cessation
-
2004
- 2004-06-09 ZA ZA200404579A patent/ZA200404579B/xx unknown
- 2004-06-16 IL IL162550A patent/IL162550A/en not_active IP Right Cessation
- 2004-06-16 MX MXPA04005892A patent/MXPA04005892A/es active IP Right Grant
-
2006
- 2006-10-26 US US11/586,576 patent/US7534776B2/en not_active Expired - Fee Related
-
2008
- 2008-09-08 AU AU2008212060A patent/AU2008212060B2/en not_active Ceased
-
2009
- 2009-03-03 JP JP2009049261A patent/JP4617382B2/ja not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2012DN01975A (fr) | ||
| HUP0204405A2 (en) | Water soluble prodrugs of azole compounds | |
| PL364598A1 (en) | Stable polymorph of flibanserin, technical process for its preparation and the use thereof for preparing medicaments | |
| BR0114316A (pt) | Processo para a preparação de formulações em pó | |
| MXPA02012795A (es) | Carvedilol. | |
| EP1040823A3 (fr) | Formulations de mousse stabiles | |
| AU4249700A (en) | Hydroxamic acid derivative | |
| GB2383041A (en) | Process for the preparation of gabapentin | |
| AU1817902A (en) | Method for the preparation of 21-hydroxy-6,19-oxidoprogesterone (21oh-6op) | |
| MXPA03008837A (es) | Una composicion farmaceutica estable de pravastatina. | |
| MXPA04004937A (es) | Proceso para preparar 3,3??,3,6??,-tetraalquil-2,2??-bifenoles y 3,??,6,??-tetraalquil-5,??-dihalo-2,??-bifenoles. | |
| AU8889998A (en) | Water soluble analogs and prodrugs of paclitaxel | |
| CA2399709A1 (fr) | Utilisation d'acide 2-methyl-thiazolidin-2,4-dicarboxylique (2-mtdc) et/ou de ses sels physiologiquement compabibles pour le traitement et/ou la prevention de cancers | |
| CA2248794A1 (fr) | Medicaments pour la prevention et le traitement d'infections virales | |
| NZ515685A (en) | Use of riluzole for the treatment of multiple sclerosis | |
| EP0900785A3 (fr) | Composés apparentés à la vitamine A et procédé pour leur préparation | |
| IL145298A0 (en) | A process for the preparation of 1,4,7,10-tetraazacyclododecane | |
| CA2353956A1 (fr) | Agent therapeutique pour le traitement de la dyserection | |
| AU2356501A (en) | Bis-basic compounds for use as tryptase inhibitors, method for producing the same and their use as medicaments | |
| ZA99440B (en) | Condensed aromatic heterocyclic cyclopentenopyridine derivative. | |
| CA2425368A1 (fr) | Nouveaux sulphoxybenzamides | |
| MXPA04003738A (es) | Composiciones farmaceuticas que contienen macrolidos. | |
| YU71400A (sh) | Poboljšani postupak za pripremanje farmaceutski dragocenih derivata norbenzomorfana | |
| MXPA04001849A (es) | Sistemas de indan-1-ol c2-disustituidos, metodo para su produccion y su uso como medicamentos. | |
| MXPA04001846A (es) | Indan-1-onas c2-substituidas y sus derivados, metodos para su produccion y su uso como medicamentos. |